170 related articles for article (PubMed ID: 22233464)
1. An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules.
Fukami N; Ramachandran S; Takenaka M; Weber J; Subramanian V; Mohanakumar T
Am J Transplant; 2012 Apr; 12(4):867-76. PubMed ID: 22233464
[TBL] [Abstract][Full Text] [Related]
2. B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease.
Xu Z; Ramachandran S; Gunasekaran M; Nayak D; Benshoff N; Hachem R; Gelman A; Mohanakumar T
Am J Transplant; 2016 Apr; 16(4):1173-82. PubMed ID: 26844425
[TBL] [Abstract][Full Text] [Related]
3. Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.
Basha HI; Ramachandran S; Tiriveedhi V; Takenaka M; Subramanian V; Nath DS; Benshoff N; Patterson GA; Mohanakumar T
Transplantation; 2013 Jan; 95(2):293-300. PubMed ID: 23325004
[TBL] [Abstract][Full Text] [Related]
4. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.
Takenaka M; Tiriveedhi V; Subramanian V; Hoshinaga K; Patterson AG; Mohanakumar T
PLoS One; 2012; 7(8):e42370. PubMed ID: 22900015
[TBL] [Abstract][Full Text] [Related]
6. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
7. T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.
Tiriveedhi V; Takenaka M; Ramachandran S; Gelman AE; Subramanian V; Patterson GA; Mohanakumar T
Am J Transplant; 2012 Oct; 12(10):2663-74. PubMed ID: 22822907
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.
Fukami N; Ramachandran S; Saini D; Walter M; Chapman W; Patterson GA; Mohanakumar T
J Immunol; 2009 Jan; 182(1):309-18. PubMed ID: 19109162
[TBL] [Abstract][Full Text] [Related]
9. The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction.
Bansal S; Itabashi Y; Perincheri S; Poulson C; Bharat A; Smith MA; Bremner RM; Mohanakumar T
Cell Immunol; 2020 Sep; 355():104172. PubMed ID: 32707293
[TBL] [Abstract][Full Text] [Related]
10. Induction of obliterative airway disease by anti-HLA class I antibodies.
Maruyama T; Jaramillo A; Narayanan K; Higuchi T; Mohanakumar T
Am J Transplant; 2005 Sep; 5(9):2126-34. PubMed ID: 16095491
[TBL] [Abstract][Full Text] [Related]
11. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
[TBL] [Abstract][Full Text] [Related]
12. A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.
Ravichandran R; Itabashi Y; Liu W; Bansal S; Rahman M; Poulson C; Fleming T; Bremner RM; Smith M; Mohanakumar T
J Heart Lung Transplant; 2021 Dec; 40(12):1517-1528. PubMed ID: 34627707
[TBL] [Abstract][Full Text] [Related]
13. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
14. Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens.
Tiriveedhi V; Takenaka M; Sarma NJ; Gelman AG; Mohanakumar T
J Heart Lung Transplant; 2013 Jul; 32(7):714-22. PubMed ID: 23643508
[TBL] [Abstract][Full Text] [Related]
15. Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.
Angaswamy N; Saini D; Ramachandran S; Nath DS; Phelan D; Hachem R; Trulock E; Patterson GA; Mohanakumar T
Hum Immunol; 2010 Jun; 71(6):560-5. PubMed ID: 20211214
[TBL] [Abstract][Full Text] [Related]
16. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen.
Higuchi T; Maruyama T; Jaramillo A; Mohanakumar T
J Immunol; 2005 Feb; 174(4):1871-8. PubMed ID: 15699113
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
[TBL] [Abstract][Full Text] [Related]
18. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet
Lendermon EA; Dodd-O JM; Coon TA; Wang X; Ensor CR; Cardenes N; Koodray CL; Heusey HL; Bennewitz MF; Sundd P; Bullock GC; Popescu I; Guo L; O'Donnell CP; Rojas M; McDyer JF
Transplant Proc; 2018 Jun; 50(5):1566-1574. PubMed ID: 29880387
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
